Christiane Stoll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christiane Stoll has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Basel M Touban
Department of Orthopaedic Surgery, Denver Health Medical Center, University of Colorado School of Medicine, 777 Bannock Street, Denver, CO 80204, USA
1 shared publication - Bryan Paul Morgan
UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University, Cardiff, UK
1 shared publication - Claudia Conrad
Department of Trauma and Reconstructive Surgery, Charité University Medical Center, Campus Benjamin Franklin, D-12207 Berlin, Germany
1 shared publication - Iris Leinhase
Department of Trauma and Reconstructive Surgery, Charité University Medical Center, Campus Benjamin Franklin, D-12207 Berlin, Germany
1 shared publication - Ivonne Persigehl
Department of Trauma and Reconstructive Surgery, Charité University Medical Center, Campus Benjamin Franklin, D-12207 Berlin, Germany
1 shared publication - Kathryn M. Beauchamp
Department of Neurosurgery, Denver Health Medical Center, University of Colorado School of Medicine, 777 Bannock Street, Denver, CO 80204, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2009
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 6 (1) , 2
Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice
Complement represents a crucial mediator of neuroinflammation and neurodegeneration after traumatic brain injury. The role of the terminal complement activation pathway, leading to generation of the membrane attack complex (MAC), has not been thoroughly investigated. CD59 is the major regulator of MAC formation and represents an essential protector from homologous cell injury after complement activation in the injured brain.
- 1 January 2009
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 6 (1) , 2
Open AccessAbsence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice
Complement represents a crucial mediator of neuroinflammation and neurodegeneration after traumatic brain injury. The role of the terminal complement activation pathway, leading to generation of the membrane attack complex (MAC), has not been thoroughly investigated. CD59 is the major regulator of MAC formation and represents an essential protector from homologous cell injury after complement activation in the injured brain.